News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders
Photo taken from Marlene Thomas/LinkedIn
Mar 3, 2024, 17:30

Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders

Marlene Thomas, Head of CGP Portfolio Strategy at Roche, shared on LinkedIn:

“I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders through this year’s program. This open dialogue is instrumental in breaking down barriers and fostering cross-sector collaborations, which can help to accelerate R&D and translate innovation into healthcare systems.

I had the pleasure to co-lead an educational session on ctDNA applications with Umberto Malapelle, Sandi Deans, Anastasios Stathis, and Daniel Shao Weng Tan.

Through liquid biopsy, we are transitioning from detecting individual mutations to gaining a holistic understanding of the disease and with this inform personalised treatment strategies.”

Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders

Source: Marlene Thomas/LinkedIn

Anastasios Stathis cancer clinical care collaborative discussions ctDNA Daniel Shao Weng Tan ESMO ESMO TAT 2024 European Society for Medical Oncology liquid biopsy Marlene Thomas OncoDaily Oncology Precision Medicine Roche Sandi Deans Targeted Anticancer Therapies Umberto Malapelle
Special Coverage
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer
Blog
Nov 13, 2024, 08:39
Eva Blondeaux on safety of pregnancy in BRCA carriers
Blog
Nov 13, 2024, 08:39
What can cancer in ferrets, opossums, and even penguins teach us about cancer in humans - AACR
Blog
Nov 13, 2024, 08:36
Research Is The Reason Nicole Seagriff had options to treat her breast cancer - The Breast Cancer Research Foundation
Blog
Nov 13, 2024, 08:30
Patrick Hwu: Exploring the unique partnership between Moffitt Cancer Center and Iovance Biotherapeutics
Insight
Nov 13, 2024, 08:27
Paolo Tarantino: The promise and challenges of response-adapted trials in breast oncology
Insight
Nov 13, 2024, 07:41
Key Factors in Menstrual Recovery for Pre-menopausal Breast Cancer on Tamoxifen
Insight
Nov 13, 2024, 07:12
Luigi Lorini was awarded the 2024 Martin "Mac" Cheever Excellence in Clinical Trial Design Travel Award for Immunoprevention
Blog
Nov 12, 2024, 23:10
Hesham ElGhazaly: Empowering Women’s Health Through Solidarity